# Bausch & Lomb

> Bausch & Lomb is a VC fund in Rochester backing Health Care and Biotechnology. See 7 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Rochester, United States
- Total investments: 7
- Last investment: Jun 2026
- Lead investor: 43%
- Last updated: Aug 2026
- X (Twitter): https://www.twitter.com/bauschlomb
- Website: http://www.bausch.com
- Facebook: https://www.facebook.com/bauschandlomb

Bausch & Lomb is a VC fund in Rochester focused on Health Care and Biotechnology. Bausch + Lomb is the eye health company dedicated to Bringing Visionary Ideas to Eye Health.They offer the world’s most comprehensive portfolio of eye health products, and They have one of the oldest, best known and most respected healthcare brands in the world.The company began in 1853 in Rochester, New York, as a small optical shop thatgrew to become a multi-billion dollar corporation with approximately 13,000 employees worldwide, and with products available in more than 100 countries.

## Contacts

5 contacts available for Bausch & Lomb. Shizune tracks 11 team members at Bausch & Lomb. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/bausch-lomb?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 43% |
| Biotechnology | 2 | 29% |
| Medical | 1 | 14% |
| Therapeutics | 1 | 14% |
| Medical Device | 1 | 14% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Grant | 1 | 14% |
| Series B | 1 | 14% |
| Series D | 1 | 14% |
| Series G | 1 | 14% |
| Funding Round | 1 | 14% |

7 stages tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Brenton Saunders | Chief Executive Officer | 9 | https://shizune.co/investors/profile/brenton-l-saunders |
| Robert Bertolini | President & CFO | 0 | https://shizune.co/investors/profile/robert-j-bertolini |
| Bob Palmisano | Executive | 0 | https://shizune.co/investors/profile/bob-palmisano |
| Chad Speegle | Territory Manager | 0 | https://shizune.co/investors/profile/chad-speegle |
| Joseph Landy | Director | 5 | https://shizune.co/investors/profile/joseph-p-landy |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Emmecell | Emmecell is a biotechnology company that provides developing cell-based therapies. |  | Corporate Round | Jun 16, 2026 |  |
| Character Biosciences | Biopharmaceutical research and development company that's an affiliate of Clover Health | $93M | Series B | Mar 25, 2025 |  |
| The Seeing Eye | The Seeing Eye is a donation based company that trains and provides seeing eye canines alongside owner training for blind individuals. | $25K | Grant | Mar 18, 2024 |  |
| AcuFocus | Acufocus, Inc., a medical device company, engages in the research, development, and marketing of solutions for the treatment of presbyopia. The company develops KAMRA, a corner inlay for the treatment of near vision loss that allows patients to see near and intermediate objects clearly; and AcuTarget, a system that is used to guide surgeons onsurgical placement of the KAMRA.It was founded in 2011 and headquartered in Irvine, California. | $21M |  | Sep 03, 2014 |  |
| AcuFocus | Acufocus, Inc., a medical device company, engages in the research, development, and marketing of solutions for the treatment of presbyopia. The company develops KAMRA, a corner inlay for the treatment of near vision loss that allows patients to see near and intermediate objects clearly; and AcuTarget, a system that is used to guide surgeons onsurgical placement of the KAMRA.It was founded in 2011 and headquartered in Irvine, California. | $21M | Series G | Sep 03, 2014 |  |
| AcuFocus | Acufocus, Inc., a medical device company, engages in the research, development, and marketing of solutions for the treatment of presbyopia. The company develops KAMRA, a corner inlay for the treatment of near vision loss that allows patients to see near and intermediate objects clearly; and AcuTarget, a system that is used to guide surgeons onsurgical placement of the KAMRA.It was founded in 2011 and headquartered in Irvine, California. | $65M | Private Equity | Nov 29, 2011 |  |
| AcuFocus | Acufocus, Inc., a medical device company, engages in the research, development, and marketing of solutions for the treatment of presbyopia. The company develops KAMRA, a corner inlay for the treatment of near vision loss that allows patients to see near and intermediate objects clearly; and AcuTarget, a system that is used to guide surgeons onsurgical placement of the KAMRA.It was founded in 2011 and headquartered in Irvine, California. | $18M | Series D | Jan 26, 2007 |  |

7 of 7 investments shown.

## Co-investors
- [Accuitive Medical Ventures](https://shizune.co/investors/profile/accuitive-medical-ventures) — VC Fund, 4 deals together
- [SV Health Investors](https://shizune.co/investors/profile/sv-life-sciences) — VC Fund, 4 deals together
- [The Carlyle Group](https://shizune.co/investors/profile/the-carlyle-group) — VC Fund, 4 deals together
- [Versant Ventures](https://shizune.co/investors/profile/versant-ventures) — VC Fund, 4 deals together
- [HealthCare Royalty Partners](https://shizune.co/investors/profile/healthcare-royalty-partners) — VC Fund, 3 deals together
- [Medtronic](https://shizune.co/investors/profile/medtronic) — VC Fund, 3 deals together

## Similar investors

### Similar stage
- [Scottish Enterprise](https://shizune.co/investors/profile/scottish-enterprise) — VC Fund
- [Foundation for Innovation and Technology (FIT)](https://shizune.co/investors/profile/foundation-pour-l-innovation-technologique) — VC Fund
- [Business Finland](https://shizune.co/investors/profile/tekes) — VC Fund

## FAQ

### What does Bausch & Lomb invest in?

Bausch & Lomb invests primarily in Health Care, Biotechnology and Medical startups, most often at Grant and Series B stage. Most of the 7 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Bausch & Lomb?

Public channels for Bausch & Lomb include X (Twitter), the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Bausch & Lomb?

The team at Bausch & Lomb includes Brenton Saunders (Chief Executive Officer), Robert Bertolini (President & CFO) and Bob Palmisano (Executive), among 11 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co